NO20064819L - Trisyklisk benzopyranforbindelse - Google Patents
Trisyklisk benzopyranforbindelseInfo
- Publication number
- NO20064819L NO20064819L NO20064819A NO20064819A NO20064819L NO 20064819 L NO20064819 L NO 20064819L NO 20064819 A NO20064819 A NO 20064819A NO 20064819 A NO20064819 A NO 20064819A NO 20064819 L NO20064819 L NO 20064819L
- Authority
- NO
- Norway
- Prior art keywords
- group
- hydrogen atom
- ring
- atom
- bond
- Prior art date
Links
- -1 benzopyran compound Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000005915 C6-C14 aryl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 1
- 125000006553 (C3-C8) cycloalkenyl group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 150000001562 benzopyrans Chemical class 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D515/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Denne oppfinnelsen vedrører benzopyranderivater med formel (I) eller (II), eller farmasøytisk akseptable salter derav hvori R' og R2 uavhengig av hverandre er hydrogenatom, Cl-6 alkylgruppe eller C6-14 arylgruppe, R3 er hydrogenatom eller Cl-6 alkylkarbonyloksygruppe, eller sammen med R4 danner en binding, R4 er hydrogenatom, eller sammen med R3 danner en binding, m er et heltall fra 0 til 4, n er et heltall fra 0 til 4, V er en enkeltbinding, CR7R8, NR9, 0, S, SO eller S02, R5 er hydrogenatom eller Cl-6alkylgruppe, R6 er hydrogenatom, C l-6 alkylgruppe, C3-8 cykloalkylgruppe, C3-8cykloalkenylgruppe, aminogruppe, Cl-6 alkylaminogruppe, diC l-6 alkylaminogruppe, C6-14 arylaminogruppe, C2-9 heteroarylaminogruppe, C6-14 arylgruppe, C2-9 heteroarylgruppe eller C2-9 heterocyklylgruppe, A er 5-, 6- eller 7-leddet ring fusjonert med benzenring, som komponentatomer i ringen kan oksygenatom, nitrogenatom eller svovelatom være inkludert i et antall av 1 til 3 alene eller i kombinasjon derav, antallet av umettede bindinger i ringen er 1, 2 eller 3 inklusive en umettet binding av benzenringen som fusjoneres, karbonatomer som utgjør ringen kan være karbonyl eller tiokarbonyl. Disse forbindelsene er anvendbare som et anti-arytmisk middel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004084605 | 2004-03-23 | ||
| PCT/JP2005/006004 WO2005090357A1 (en) | 2004-03-23 | 2005-03-23 | Tricyclic benzopyran compound as anti-arrhythmic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20064819L true NO20064819L (no) | 2006-10-23 |
| NO339495B1 NO339495B1 (no) | 2016-12-19 |
Family
ID=34962589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20064819A NO339495B1 (no) | 2004-03-23 | 2006-10-23 | Trisyklisk benzopyranforbindelse |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US7652008B2 (no) |
| EP (1) | EP1732929B1 (no) |
| JP (1) | JP4840594B2 (no) |
| KR (2) | KR101085979B1 (no) |
| CN (3) | CN102190661B (no) |
| AT (1) | ATE485299T1 (no) |
| AU (2) | AU2005223612B2 (no) |
| BR (1) | BRPI0508768A (no) |
| CA (1) | CA2558139C (no) |
| CY (1) | CY1111250T1 (no) |
| CZ (1) | CZ2006598A3 (no) |
| DE (1) | DE602005024245D1 (no) |
| DK (1) | DK1732929T3 (no) |
| EG (1) | EG27163A (no) |
| ES (1) | ES2353021T3 (no) |
| HR (1) | HRP20110005T1 (no) |
| IL (1) | IL177950A (no) |
| MX (1) | MXPA06010880A (no) |
| NO (1) | NO339495B1 (no) |
| NZ (2) | NZ549570A (no) |
| PL (1) | PL1732929T3 (no) |
| PT (1) | PT1732929E (no) |
| RS (1) | RS51742B (no) |
| RU (1) | RU2380370C2 (no) |
| SI (1) | SI1732929T1 (no) |
| SK (1) | SK287994B6 (no) |
| TW (1) | TWI352704B (no) |
| UA (1) | UA91189C2 (no) |
| WO (1) | WO2005090357A1 (no) |
| ZA (1) | ZA200607388B (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005223612B2 (en) * | 2004-03-23 | 2010-06-24 | Nissan Chemical Industries, Ltd. | Tricyclic benzopyran compound as anti-arrhythmic agents |
| WO2007105658A1 (ja) | 2006-03-10 | 2007-09-20 | Nissan Chemical Industries, Ltd. | 光学活性クロメンオキシド化合物の製造方法 |
| JPWO2010018867A1 (ja) * | 2008-08-14 | 2012-01-26 | 日産化学工業株式会社 | ジ置換ベンゾピラン化合物 |
| UA105385C2 (uk) * | 2009-04-30 | 2014-05-12 | Ниссан Кэмикал Индастриз, Лтд. | Кристалічна форма сполуки трициклічного бензопірану і спосіб її отримання (варіанти) |
| ES2639065T5 (es) | 2009-06-25 | 2023-01-30 | Alkermes Pharma Ireland Ltd | Compuestos heterocíclicos para el tratamiento de trastornos neurológicos y psicológicos |
| IN2015DN03012A (no) * | 2012-09-27 | 2015-10-02 | Nissan Chemical Ind Ltd | |
| JP6202280B2 (ja) * | 2012-09-27 | 2017-09-27 | 日産化学工業株式会社 | 含窒素複素環ｎ−オキシド化合物の製造方法 |
| WO2015012271A1 (ja) * | 2013-07-25 | 2015-01-29 | 日産化学工業株式会社 | 複素環化合物の製造方法 |
| CN110177796B (zh) * | 2017-01-06 | 2022-04-08 | 阿斯克里斯有限公司 | 喹啉酮衍生物及其用于预防或治疗变应性疾病的药物组合物 |
| AU2019230014B2 (en) | 2018-03-05 | 2024-11-28 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
| CN108727261B (zh) * | 2018-06-21 | 2021-09-24 | 济南大学 | 一种硝基取代喹那啶的制备方法 |
| JP7468869B2 (ja) * | 2018-12-28 | 2024-04-16 | 国立大学法人大阪大学 | 遺伝性徐脈性不整脈治療薬 |
| RU2754610C1 (ru) * | 2020-04-14 | 2021-09-03 | Георгий Викторович ТЕЦ | Препарат для лечения заболеваний, вызванных бактериями |
| US20230241053A1 (en) * | 2020-06-26 | 2023-08-03 | Osaka University | Therapeutic agent for drug-induced bradycardia and bradyarrhythmia |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZM7682A1 (en) | 1981-09-25 | 1983-05-23 | Beecham Group Plc | Active compounds |
| JPS5867683U (ja) | 1981-10-28 | 1983-05-09 | 株式会社ナムコ | 歩行ロボツト |
| JPH0699439B2 (ja) * | 1988-02-03 | 1994-12-07 | 日産化学工業株式会社 | ピラノベンゾオキサジアゾール誘導体 |
| JP2658198B2 (ja) * | 1988-06-23 | 1997-09-30 | 日産化学工業株式会社 | ピラノベンゾトリアゾール誘導体 |
| US5097037A (en) * | 1989-07-17 | 1992-03-17 | Nissan Chemical Industries, Ltd. | Process for the optical resolution of pyranobenzoxadiazole compounds |
| JP2876712B2 (ja) * | 1989-07-17 | 1999-03-31 | 日産化学工業株式会社 | 光学活性ピラノベンゾオキサジアゾール誘導体 |
| US5164509A (en) * | 1990-11-26 | 1992-11-17 | E. R. Squibb & Sons, Inc. | Benzodiazolo analogs |
| JPH07300414A (ja) * | 1993-04-02 | 1995-11-14 | Nissan Chem Ind Ltd | 心不全治療薬 |
| UA27973C2 (uk) * | 1993-04-02 | 2000-10-16 | Ніссан Кемікал Індастріз Лтд | Лікарський засіб для лікування серцевої недостатності |
| JP2734457B2 (ja) | 1994-02-23 | 1998-03-30 | 日産化学工業株式会社 | 不斉エポキシ化反応 |
| WO1995034547A1 (en) * | 1994-06-10 | 1995-12-21 | Smithkline Beecham Plc | C-4 amide substituted compounds and their use as therapeutic agents |
| EP0807629B1 (de) * | 1996-05-15 | 2004-03-03 | Aventis Pharma Deutschland GmbH | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| AU3959099A (en) | 1998-06-03 | 1999-12-20 | Nissan Chemical Industries Ltd. | Indan derivatives |
| WO2000012492A1 (en) | 1998-09-01 | 2000-03-09 | Nissan Chemical Industries, Ltd. | Benzoxazine derivatives |
| AU2830800A (en) | 1999-03-25 | 2000-10-16 | Nissan Chemical Industries Ltd. | Chroman derivatives |
| CN1167697C (zh) * | 1999-09-17 | 2004-09-22 | 日产化学工业株式会社 | 苯并吡喃衍生物 |
| EP1214307B1 (en) | 1999-09-24 | 2004-04-07 | Nissan Chemical Industries, Ltd. | 4-oxybenzopyran derivative |
| US6677371B1 (en) | 1999-10-05 | 2004-01-13 | Nissan Chemical Industries, Ltd. | 4-oxybenzopyran derivative |
| TW589305B (en) | 2001-02-14 | 2004-06-01 | Nissan Chemical Ind Ltd | 4-aminobenzopyran derivatives |
| IL159218A0 (en) | 2001-06-25 | 2004-06-01 | Nissan Chemical Ind Ltd | Substituted benzopyran derivatives against arrhythmia |
| WO2003014113A1 (en) | 2001-08-06 | 2003-02-20 | Glenmark Pharmaceuticals Limited | Novel benzopyran compounds and process for their preparation and use |
| AU2005223612B2 (en) * | 2004-03-23 | 2010-06-24 | Nissan Chemical Industries, Ltd. | Tricyclic benzopyran compound as anti-arrhythmic agents |
-
2005
- 2005-03-23 AU AU2005223612A patent/AU2005223612B2/en not_active Ceased
- 2005-03-23 JP JP2006530022A patent/JP4840594B2/ja not_active Expired - Lifetime
- 2005-03-23 US US10/590,975 patent/US7652008B2/en active Active
- 2005-03-23 RU RU2006137284/04A patent/RU2380370C2/ru not_active IP Right Cessation
- 2005-03-23 WO PCT/JP2005/006004 patent/WO2005090357A1/en not_active Ceased
- 2005-03-23 DK DK05727581.0T patent/DK1732929T3/da active
- 2005-03-23 ES ES05727581T patent/ES2353021T3/es not_active Expired - Lifetime
- 2005-03-23 AT AT05727581T patent/ATE485299T1/de active
- 2005-03-23 MX MXPA06010880A patent/MXPA06010880A/es active IP Right Grant
- 2005-03-23 UA UAA200611101A patent/UA91189C2/ru unknown
- 2005-03-23 CN CN2011100751168A patent/CN102190661B/zh not_active Expired - Fee Related
- 2005-03-23 CN CN2005800090295A patent/CN1934116B/zh not_active Expired - Lifetime
- 2005-03-23 SI SI200531171T patent/SI1732929T1/sl unknown
- 2005-03-23 RS RS20110028A patent/RS51742B/sr unknown
- 2005-03-23 SK SK5079-2006A patent/SK287994B6/sk not_active IP Right Cessation
- 2005-03-23 PL PL05727581T patent/PL1732929T3/pl unknown
- 2005-03-23 EP EP05727581A patent/EP1732929B1/en not_active Expired - Lifetime
- 2005-03-23 CA CA2558139A patent/CA2558139C/en not_active Expired - Fee Related
- 2005-03-23 TW TW094108962A patent/TWI352704B/zh not_active IP Right Cessation
- 2005-03-23 CZ CZ20060598A patent/CZ2006598A3/cs unknown
- 2005-03-23 CN CN2008101707921A patent/CN101429200B/zh not_active Expired - Fee Related
- 2005-03-23 PT PT05727581T patent/PT1732929E/pt unknown
- 2005-03-23 HR HR20110005T patent/HRP20110005T1/hr unknown
- 2005-03-23 DE DE602005024245T patent/DE602005024245D1/de not_active Expired - Lifetime
- 2005-03-23 ZA ZA200607388A patent/ZA200607388B/en unknown
- 2005-03-23 KR KR1020107027058A patent/KR101085979B1/ko not_active Expired - Fee Related
- 2005-03-23 NZ NZ549570A patent/NZ549570A/en not_active IP Right Cessation
- 2005-03-23 KR KR1020067021988A patent/KR101019402B1/ko not_active Expired - Lifetime
- 2005-03-23 NZ NZ585606A patent/NZ585606A/en not_active IP Right Cessation
- 2005-03-23 BR BRPI0508768-6A patent/BRPI0508768A/pt not_active Application Discontinuation
-
2006
- 2006-09-02 EG EGNA2006000900 patent/EG27163A/xx active
- 2006-09-07 IL IL177950A patent/IL177950A/en not_active IP Right Cessation
- 2006-10-23 NO NO20064819A patent/NO339495B1/no not_active IP Right Cessation
-
2009
- 2009-11-17 US US12/591,353 patent/US7964623B2/en not_active Expired - Fee Related
-
2010
- 2010-07-08 AU AU2010202900A patent/AU2010202900B2/en not_active Ceased
-
2011
- 2011-01-19 CY CY20111100060T patent/CY1111250T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111250T1 (el) | Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων | |
| MY139988A (en) | Macrocylic inhibitors of hepatitis c virus | |
| CY1109222T1 (el) | Παραγωγο συγχωνευμενης κινολινης και χρηση του | |
| HUP0300138A2 (en) | Cyclic amine derivatives as ccr5 antagonists, their production and use and pharmaceutical compositions containing them | |
| YU79502A (sh) | Novi,sporodelujući betamimetici,postupak za njihovo pripremanje i njihova primena kao lekova | |
| MX9504287A (es) | Derivados de camptotecina y proceso para su preparacion. | |
| EP0798292A4 (en) | Aniline derivatives having nitrogen monoxide synthase inhibitory activity | |
| TW200738667A (en) | Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof | |
| EP1479684A4 (en) | THIENOPYRIMIDINES, METHODS OF MAKING AND USING SAME | |
| NZ505927A (en) | Cyclobutene-1,2-dione derivatives for use in the inhibition of an ileal bile acid transporter | |
| ES2199696A1 (es) | Mezclas de estabilizantes | |
| DE69525763D1 (de) | 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENE, DIE LDL OXIDATION HEMMEN | |
| AR035375A1 (es) | Compuesto derivado de pirrol sustituido, composicion farmaceutica y su uso en la fabricacion de un medicamento para inhibir la farnesiltransferasa | |
| MXPA02007973A (es) | Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece. | |
| DE69926776D1 (de) | Quinalozinon-derivate | |
| MXPA01013148A (es) | Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico. | |
| EA199901050A3 (ru) | Новые соединения имидазолина, способ их получения и содерщащие их фармацевтические композиции | |
| ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
| CA2440186A1 (en) | Medicinal composition containing 1,3-thiazine derivative | |
| IL136510A0 (en) | Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same | |
| DE60028475D1 (de) | Stabilisatormischung | |
| DK1546096T3 (da) | Fremgangsmåde til fremstilling af aminopyrrolidinderivater | |
| ATE502034T1 (de) | Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung | |
| DK1200442T3 (da) | Derivater af 2,3-benzodiazepin | |
| TH61861A3 (th) | 4-ออกโซ-1,4-ไดไฮโดร-3-ควิโนลีนคาร์บอกซามีดที่เป็นตัวกระทำต้านเชื้อไวรัส |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |